| Hepatitis C virus RNA assays: current and emerging technologies and their clinical applications RR Al Olaby, HME Azzazy Expert review of molecular diagnostics 11 (1), 53-64, 2011 | 54 | 2011 |
| Glucocorticoid-induced fetal origins of adult hypertension: Association with epigenetic events EAH Anwar MA, Saleh AI, Al Olabi R, Al Shehabi TS Vascular Pharmacology 77, S1537-1891, 2016 | 42* | 2016 |
| A Randomized Controlled Trial of Sertraline in Young Children With Autism Spectrum Disorder RJH Laura A. Potter, Danielle A. Scholze, Hazel Maridith B. Biag, Andrea ... Frontiers in Psychiatry 10, 2019 | 33 | 2019 |
| A Randomized Controlled Trial of Sertraline in Young Children With Autism Spectrum Disorder Front. Psychiatry, 2019 | 33 | 2019 |
| Molecular biomarkers predictive of sertraline treatment response in young children with fragile X syndrome RR AlOlaby, SR Sweha, M Silva, B Durbin-Johnson, CM Yrigollen, ... Brain and Development 39 (6), 483-492, 2017 | 33 | 2017 |
| Altered expression of the FMR1 splicing variants landscape in premutation carriers E Tseng, HT Tang, RR AlOlaby, L Hickey, F Tassone Biochim Biophys Acta., 2017 | 31 | 2017 |
| Identification of a novel drug lead that inhibits HCV infection and cell-to-cell transmission by targeting the HCV E2 glycoprotein RR Al Olaby, L Cocquerel, A Zemla, L Saas, J Dubuisson, J Vielmetter, ... PloS one 9 (10), e111333, 2014 | 26 | 2014 |
| Clinical and molecular correlates in fragile X premutation females P Jiraanont, SR Sweha, RR AlOlaby, M Silva, HT Tang, B Durbin-Johnson, ... Eneurologicalsci 7, 49-56, 2017 | 14 | 2017 |
| Identification of ligands that target the HCV-E2 binding site on CD81 RA Olaby, HM Azzazy, R Harris, B Chromy, J Vielmetter, R Balhorn Journal of computer-aided molecular design 27, 337-346, 2013 | 10 | 2013 |
| Differential Methylation Profile in Fragile X Syndrome-Prone Offspring Mice after in Utero Exposure to Lactobacillus Reuteri RR AlOlaby, M Zafarullah, M Barboza, G Peng, BJ Varian, SE Erdman, ... Genes 13 (8), 1300, 2022 | 9 | 2022 |
| Maternal microbiota modulate a fragile X-like syndrome in offspring mice BJ Varian, KT Weber, LJ Kim, TE Chavarria, SE Carrasco, S Muthupalani, ... Genes 13 (8), 1409, 2022 | 8 | 2022 |
| Profiling Genome-Wide DNA Methylation in Children with Autism Spectrum Disorder and in Children with Fragile X Syndrome FT Mittal Jasoliya, Jianlei Gu, Reem R. AlOlaby, Blythe Durbin-Johnson ... Genes 13, 1795, 2022 | 5 | 2022 |
| Assessment of molecular measures in non-FXTAS male premutation carriers RR Al Olaby, HT Tang, B Durbin-Johnson, A Schneider, D Hessl, ... Frontiers in Genetics 9, 302, 2018 | 4 | 2018 |
| The woes of Egyptian PhD students H Zohny Nature Middle East, 2011 | 2 | 2011 |
| IDENTIFICATION OF MOLECULAR BIOMARKERS PREDICTIVE OF RESPONSE TO TARGETED TREATMENT IN FRAGILE X SYNDROME AND AUTISM SPECTRUM DISORDER RR Al Olaby, R Hagerman, L Abbeduto, F Tassone JOURNAL OF INTELLECTUAL DISABILITY RESEARCH 61 (9), 828-828, 2017 | 1 | 2017 |
| Ligands that target hepatitis c virus e2 protein R Al-Olaby, H Azzazy, R Balhorn US Patent App. 15/121,691, 2016 | 1 | 2016 |
| GLOBAL METHYLATION PROFILING IN CHILDREN WITH AUTISM SPECTRUM DISORDER AND IN CHILDREN WITH FRAGILE X SYNDROME M Jasoliya, R Al Olaby, T Tang, J Gu, Y Zhu, B Johnson, F Chedin, ... JOURNAL OF INTELLECTUAL DISABILITY RESEARCH 65 (9), 809-809, 2021 | | 2021 |
| Ligands that target Plasmodium sporozoite binding sites on CD81 and therapeutic methods using them H Azzazy, R Al-Olaby, R Balhorn US Patent 10,548,895, 2020 | | 2020 |
| The loss of β adrenergic receptor mediated release potentiation in a mouse model of fragile X syndrome R Martín, N García Font, MI Torres Molina, MJ Oset Gasque, ... Elsevier, 2019 | | 2019 |
| Clinical and molecular correlates in fragile X premutation females PJ Stefan Sweha, Reem R. Al Olabi, Marisol Silva, Hiu-Tung Tang, Blythe ... eNeurologicalSci, 2017 | | 2017 |
Hassan M. E. AzzazyDistinguished University Professor & Chemistry Chairman, American University in Cairo在 aucegypt.edu 的电子邮件经过验证
